采纳股份收盘上涨1.66%，滚动市盈率77.63倍，总市值27.74亿元

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Canar Medical Co., which has a current PE ratio of 77.63, marking a new low in 78 days, with a total market capitalization of 2.774 billion yuan [1][2] - Canar Medical's main business includes the research, production, and sales of injection and puncture instruments and laboratory consumables, and it has been recognized as a specialized and innovative small and medium-sized enterprise in Jiangsu Province [1] - The latest quarterly report for Q1 2025 shows that Canar Medical achieved operating revenue of 72.7093 million yuan, a year-on-year decrease of 34.28%, and a net profit of 7.6802 million yuan, down 69.34% year-on-year, with a gross profit margin of 31.15% [1] Group 2 - In terms of industry comparison, the average PE ratio for the medical device industry is 52.71, with a median of 37.14, positioning Canar Medical at the 98th rank within the industry [1][2] - The number of shareholders for Canar Medical has increased to 7,596, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1]